New blood test could sniff out liver cancer before It's too late
NCT ID NCT07148310
First seen Nov 01, 2025 · Last updated Jun 05, 2026 · Updated 33 times
Summary
This study is testing a new blood test called Delta-HLD to see if it can accurately detect liver cancer (hepatocellular carcinoma). Researchers will compare results from 200 people—half with liver cancer and half with cirrhosis but no cancer—to measure how sensitive and specific the test is. If successful, this liquid biopsy could offer a less invasive way to catch liver cancer earlier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATO CELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Epiliquid
RECRUITINGMendoza, 5500, Argentina
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.